Your browser doesn't support javascript.
loading
Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal.
Abdelghani, Mohammad; Soliman, Osama I I; Schultz, Carl; Vahanian, Alec; Serruys, Patrick W.
Afiliação
  • Abdelghani M; Academic Medical Center, Amsterdam, The Netherlands.
  • Soliman OI; Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands Cardialysis Core Laboratories and Clinical Trial Management, Rotterdam, The Netherlands.
  • Schultz C; Cardiology Department, Royal Perth Hospital, Perth, Australia School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.
  • Vahanian A; Cardiology Department, Bichat University Hospital, Paris, France.
  • Serruys PW; Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands International Centre for Circulatory Health, NHLI, Imperial College London, London, UK patrick.w.j.c.serruys@gmail.com.
Eur Heart J ; 37(34): 2627-44, 2016 Sep 07.
Article em En | MEDLINE | ID: mdl-27075871
ABSTRACT
Paravalvular leakage (PVL) is an important complication of transcatheter aortic valve implantation (TAVI). It contributed to the erosion of the clinical benefits of TAVI and confidence of its adoption as a default therapy in low surgical-risk patients. Newer TAVI technologies are provided with effective paravalvular sealing as well as retrieval/reposition mechanisms that are believed to considerably lower the risk of PVL. Meanwhile, developments in timely detection and accurate quantitation of PVL remain lagging behind those technological advances. The Valve Academic Research Consortium-standardized criteria of PVL assessment are based on echocardiography and are, according to experts' opinion, not adequately validated. Peri-procedural diagnosis, based on angiographic, haemodynamic, and/or echocardiographic methods, is so far without standardization of acquisition or interpretation. The aim of this report is to review the strengths and limitations of the current technologies used for PVL adjudication. Understanding this strengths/limitations ratio is important to define an appropriate scheme for detection and quantitation of PVLs both in clinical trials and in routine clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Valva Aórtica Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Valva Aórtica Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article